Introducing new vaccines in low- and middle-income countries: challenges and approaches

Autor: Adrienne Guignard, Nicolas Praet, Viviane Jusot, Marina Bakker, Laurence Baril

Publikováno v: Expert Review of Vaccines, Vol 18, Iss 2, Pp 119-131 (2019)

Introduction: The number of new vaccine introductions (NVIs) in low and middle-income countries (LMICs) has markedly increased since 2010, raising challenges to often overstretched and underfunded health care systems. Areas covered: We present an ove

Externí odkaz: https://doaj.org/article/e50e9344daf340a3ba1561da53d3cf6c

Introducing new vaccines in low- and middle-income countries: challenges and approaches

Autor: Nicolas Praet, Adrienne Guignard, Laurence Baril, Viviane Jusot, Marina Bakker

Publikováno v: Expert Review of Vaccines. 18:119-131

The number of new vaccine introductions (NVIs) in low and middle-income countries (LMICs) has markedly increased since 2010, raising challenges to often overstretched and underfunded health care systems.We present an overview of some of these challen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba84ac31b365047a63caa96419e50e1c
https://doi.org/10.1080/14760584.2019.1574224

PHARMO Database Network

Autor: Marina Bakker, Ron M. C. Herings

Publikováno v: Databases for Pharmacoepidemiological Research ISBN: 9783030514549

The first linkage of healthcare databases that laid the basis for the PHARMO Database Network dates back to the first quarter of 1989 and was an initiative of Prof. Dr. B.Ch. Stricker and Dr. R.M.C. Herings. Drug exposure files of community pharmacie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a2a3fd96686d7d52c6b84107c4aa9c5
https://doi.org/10.1007/978-3-030-51455-6_7

Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer : A systematic review and meta-analysis

Autor: Myrthe P. P. van Herk-Sukel, Jetty A. Overbeek, Giel Nijpels, Marina Bakker, Ron M. C. Herings, Amber A. van der Heijden

Publikováno v: Diabetes/Metabolism Research and Reviews, 34(5), e3004. John Wiley and Sons Ltd
Overbeek, J A, Bakker, M, van der Heijden, A A W A, van Herk-Sukel, M P P, Herings, R M C & Nijpels, G 2018, ' Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis ', Diabetes/Metabolism Research and Reviews, vol. 34, no. 5, e3004 . https://doi.org/10.1002/dmrr.3004

The long-term impact of dipeptidyl peptidase-4 (DPP-4) inhibition is unknown, and there are concerns about the influence of DPP-4 inhibition on carcinogenesis of the pancreas and thyroid. As DPP-4 is a rather unselective enzyme present in many tissue

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11bdb1cc7825e2c68916da321c8dbf44
https://dspace.library.uu.nl/handle/1874/377281

The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature

Autor: Xavier Castellsagué, Marina Bakker, Eveline M Bunge, Sylvia Taylor

Publikováno v: BMC Infectious Diseases
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

Background Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women and their provision remains a major public health need. However, HPV is also a major cause of non-cervical anogenital and oropharyngeal cancers and the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500c50b39c45479a77aa330ee5cdff01
http://europepmc.org/articles/PMC4908763